Skip Navigation


Human Reproduction Update Advance Access originally published online on August 16, 2008
Human Reproduction Update 2008 14(6):593-604; doi:10.1093/humupd/dmn032
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
14/6/593    most recent
dmn032v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nyboe Andersen, A.
Right arrow Articles by Loft, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nyboe Andersen, A.
Right arrow Articles by Loft, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Trends in the use of intracytoplasmatic sperm injection marked variability between countries

Anders Nyboe Andersen1, Elisabeth Carlsen and Anne Loft

The Fertility Clinic, section 4071, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100 Copenhagen, Denmark

1 Correspondence address. Tel: +45-35451315; Fax: +45-35454946; E-mail: anders.nyboe.andersen{at}rh.regionh.dk

BACKGROUND: ICSI is used increasingly often compared with standard IVF. The aim of the present study was to analyse the changes in the use of ICSI, and discuss possible causes and consequences.

METHODS: Data from National and Regional registers were analysed for trends in the use of ICSI and indications for assisted reproductive technology (ART).

RESULTS: The use of ICSI increased from 39.6% of ART cycles in 1997 to 58.9% in 2004 (USA 57.5%, Australia/New Zealand 58.6%, Europe 59.3%). The Nordic countries, the Netherlands and the UK used ICSI to a low extent (40.0–44.3%), whereas Austria, Belgium and Germany (68.5–72.9%) and the southern European countries like Greece, Italy and Spain used ICSI frequently (66.0–81.2%). The marked increase in the proportion of ICSI cycles seems primarily due to an increased use in couples classified as having mixed causes of infertility, unexplained infertility and advanced age together with a relative decline in tubal factor infertility. An absolute increase in the prevalence of couples with impairment in semen quality remains a possibility.

CONCLUSIONS: ICSI is used increasingly, but huge differences exist between countries within Europe. It is not possible to determine specific factors that explain the differences. As ICSI does not give higher pregnancy rates than IVF in couples without male factors, and as it adds additional costs, infertile couples and society may benefit from a less frequent use of ICSI in some countries.

Key words: ICSI / trends over time / indications / national registers

Received on April 23, 2008; revised June 23, 2008; accepted on July 2, 2008


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
R. Ivell and F. Grutzner
Evolution and Male Fertility: Lessons from the Insulin-Like Factor 6 Gene (Insl6)
Endocrinology, September 1, 2009; 150(9): 3986 - 3990.
[Full Text] [PDF]


Home page
Hum ReprodHome page
A. Nyboe Andersen, V. Goossens, S. Bhattacharya, A.P. Ferraretti, M.S. Kupka, J. de Mouzon, K.G. Nygren, and The European IVF-monitoring (EIM) Consortium, for
Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE: ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE)
Hum. Reprod., June 1, 2009; 24(6): 1267 - 1287.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.